Search results
Results from the WOW.Com Content Network
An ultrasound showing an embryo measured to have a crown-rump length of 1.67 cm and estimated to have a gestational age of 8 weeks and 1 day. Crown-rump length (CRL) is the measurement of the length of human embryos and fetuses from the top of the head (crown) to the bottom of the buttocks (rump).
The Neonatal Behavioral Assessment Scale (NBAS), also known as the Brazelton Neonatal Assessment Scale (BNAS), [1] was developed in 1973 by T. Berry Brazelton and his colleagues. [2] This test purports to provide an index of a newborn's abilities, and is usually given to an infant somewhere between the age of 3 days to 4 weeks old. [1]
A biophysical profile (BPP) is a prenatal ultrasound evaluation of fetal well-being involving a scoring system, [1] with the score being termed Manning's score. [2] It is often done when a non-stress test (NST) is non reactive, or for other obstetrical indications.
The Ballard Maturational Assessment, Ballard Score, or Ballard Scale, is a commonly used technique of gestational age assessment. It was devised by Dr Jeanne L. Ballard, professor emeritus of Pediatrics, Obstetrics and Gynecology at the University of Cincinnati College of Medicine.
Overdiagnosis is the diagnosis of disease that will never cause symptoms or death during a patient's ordinarily expected lifetime [1] and thus presents no practical threat regardless of being pathologic. Overdiagnosis is a side effect of screening for early forms of disease.
The obstetric history of a female who has had four pregnancies, one of which was a miscarriage before 20 weeks, would be noted in the GPA system as G 4 P 3 A 1 and in the GP system as G 4 P 3. The obstetric history of a female who has had one pregnancy of twins with successful outcomes would be noted as G 1 P 1+1 .
The triple test, also called triple screen, the Kettering test or the Bart's test, is an investigation performed during pregnancy in the second trimester to classify a patient as either high-risk or low-risk for chromosomal abnormalities (and neural tube defects). The term "multiple-marker screening test" is sometimes used instead.
The scoring assessment is based upon the pathological significance and severity of the symptoms. Symptoms can be managed with medication. Though lengthy, it remains when used by trained clinicians. Bias and subjectivity can have some affect. The Finnegan scale is also used to assess the effectiveness of treatment and recovery of the infant.